An open-label study of quetiapine for delirium
Objective: To evaluate the effects of quetiapine treatment in patients with delirium. Material and Method: All patients with delirium were assessed. The diagnosis of delirium was confirmed by using the Confusion Assessment Method (CAM). Quetiapine at the dose between 25 and 100 mg /day was given for...
Saved in:
Main Authors: | Benchalak Maneeton, Narong Maneeton, Manit Srisurapanont |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=35948980100&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/61250 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
An open-label study of quetiapine for delirium
by: Maneeton B., et al.
Published: (2014) -
Quetiapine versus haloperidol in the treatment of delirium: A double-blind, randomized, controlled trial
by: Benchalak Maneeton, et al.
Published: (2018) -
Quetiapine versus haloperidol in the treatment of delirium: A double-blind, randomized, controlled trial
by: Benchalak Maneeton, et al.
Published: (2018) -
Quetiapine versus typical antipsychotic medications for schizophrenia
by: Sirijit Suttajit, et al.
Published: (2018) -
Quetiapine versus typical antipsychotic medications for schizophrenia
by: Sirijit Suttajit, et al.
Published: (2018)